GI & Endoscopy

While much is known about the coronavirus' ability to shut down lungs, new research suggests the virus can affect other organs in the body including those in the digestive tract, The Washington Post reports.

Private equity-backed management service organization United Digestive responded to the COVID-19 pandemic in full force and has begun talks on how it will restart its practice once the pandemic begins to subside.

Here are five updates from gastroenterology companies, organizations and practices from the past week: 

The COVID-19 pandemic is devastating private practice gastroenterologists, resulting in layoffs, reduced hours and decreased salaries to try and stay afloat, MDedge reports.

Two years ago, when Mississippi-based gastroenterologist Dr. Reed Hogan, M.D. suggested adding nonalcoholic fatty liver disease (NAFLD) as a comprehensive ancillary service to the physicians at his practice, they nearly laughed him out of the room. Now, Dr. Hogan and…

The American Gastroenterological Association released guidance for gastroenterologists treating patients with inflammatory bowel disease.

Rochester, Minn.-based Mayo Clinic has a $3 billion systemwide deficit that is forcing a series of operational changes, the Jacksonville Business Journal reports.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 6-10:

Private equity firm Webster Equity Partners partnered with Memphis, Tenn.-based Gastro One April 8, creating gastroenterology's seventh PE-backed platform, One GI, in the process.

Exact Sciences completed 1.69 million Cologuard tests in 2019, and while the test was found to have 92 percent sensitivity and 87 percent specificity rates for detecting colorectal cancer, it remains divisive in the medical community.